Literature DB >> 20417260

Soluble recombinant human metapneumovirus G protein is immunogenic but not protective.

Alex B Ryder1, Sharon J Tollefson, Amy B Podsiad, Joyce E Johnson, John V Williams.   

Abstract

Human metapneumovirus (HMPV) expresses the major surface glycoproteins F and G. We evaluated the protective efficacy of immunization with G. We generated a recombinant form of G ectodomain (GDeltaTM) that was secreted from mammalian cells and purified by affinity chromatography. We tested the immunogenicity of GDeltaTM in cotton rats. Animals were immunized with PBS, GDeltaTM alone or adjuvanted, or were infected once with HMPV, and challenged with live HMPV at 28 days. Animals vaccinated with adjuvanted and non-adjuvanted GDeltaTM developed high levels of serum antibodies to both recombinant and native G protein; however, vaccinated animals did not develop neutralizing antibodies and were not protected against virus challenge. Unlike the analogous non-fusion glycoproteins of other human paramyxoviruses, HMPV G does not appear to be a protective antigen. This represents an unusual feature of HMPV. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417260      PMCID: PMC2894472          DOI: 10.1016/j.vaccine.2010.04.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein.

Authors:  T Spector
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

3.  Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.

Authors:  M E Hamelin; S Côté; J Laforge; N Lampron; J Bourbeau; K Weiss; R Gilca; G DeSerres; G Boivin
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

4.  The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.

Authors:  John V Williams; Sharon J Tollefson; Joyce E Johnson; James E Crowe
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections.

Authors:  John V Williams; Rodrigo Martino; Núria Rabella; Magdalena Otegui; Rocio Parody; Joshua M Heck; James E Crowe
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

6.  Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.

Authors:  Stéphane Biacchesi; Mario H Skiadopoulos; Lijuan Yang; Elaine W Lamirande; Kim C Tran; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease.

Authors:  Richard A Martinello; Frank Esper; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn
Journal:  J Infect       Date:  2006-01-10       Impact factor: 6.072

8.  A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.

Authors:  Roderick S Tang; Kutubuddin Mahmood; Mia Macphail; Jeanne M Guzzetta; Aurelia A Haller; Hui Liu; Jasmine Kaur; Heather A Lawlor; Elizabeth A Stillman; Jeanne H Schickli; Ron A M Fouchier; Albert D M E Osterhaus; Richard R Spaete
Journal:  Vaccine       Date:  2005-02-25       Impact factor: 3.641

9.  Antigenic and genetic variability of human metapneumoviruses.

Authors:  Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

10.  Human metapneumovirus and chronic obstructive pulmonary disease.

Authors:  Diego Vicente; Milagrosa Montes; Gustavo Cilla; Emilio Pérez-Trallero
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

View more
  15 in total

Review 1.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 2.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  Genomic analysis of four human metapneumovirus prototypes.

Authors:  Rohith Piyaratna; Sharon J Tollefson; John V Williams
Journal:  Virus Res       Date:  2011-06-28       Impact factor: 3.303

4.  Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.

Authors:  Reagan G Cox; John J Erickson; Andrew K Hastings; Jennifer C Becker; Monika Johnson; Ryan E Craven; Sharon J Tollefson; Kelli L Boyd; John V Williams
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins.

Authors:  Reagan G Cox; S Brent Livesay; Monika Johnson; Melanie D Ohi; John V Williams
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

6.  Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Authors:  Sherry C Wen; Jennifer E Schuster; Pavlo Gilchuk; Kelli L Boyd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 7.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

8.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

Review 9.  Human metapneumovirus in adults.

Authors:  Lenneke E M Haas; Steven F T Thijsen; Leontine van Elden; Karen A Heemstra
Journal:  Viruses       Date:  2013-01-08       Impact factor: 5.048

10.  Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay.

Authors:  Patricia Sastre; Tamara Ruiz; Oliver Schildgen; Verena Schildgen; Carmen Vela; Paloma Rueda
Journal:  Virol J       Date:  2012-07-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.